Clinical pharmacology. Possible clinical importance of genetic differences in drug metabolism.
- 22 August 1981
- Vol. 283 (6290), 537-542
- https://doi.org/10.1136/bmj.283.6290.537
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Genetic differences in susceptibility to chemically induced myelotoxicity and leukemia.Environmental Health Perspectives, 1981
- Gene conversion: Some implications for immunoglobulin genesCell, 1981
- Why individuals vary in their response to drugsTrends in Pharmacological Sciences, 1980
- Multiple forms of inducible drug-metabolizing enzymes: A reasonable mechanism by which any organism can cope with adversityMolecular and Cellular Biochemistry, 1979
- Polymorphisms of Oxidation at Carbon Centers of Drugs and Their Clinical SignificanceDrug Metabolism Reviews, 1979
- Organization, Transcription, and Regulation in the Animal GenomeThe Quarterly Review of Biology, 1973
- BIOCHEMICAL AND GENETIC FACTORS REGULATING DILANTIN METABOLISM IN MAN*Annals of the New York Academy of Sciences, 1971
- The Second Reported Kindred with Hereditary Resistance to Oral Anticoagulant DrugsNew England Journal of Medicine, 1970
- Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency in GoutAnnals of Internal Medicine, 1969
- Increased plasma cholinesterase activity and succinylcholine resistance: a genetic variant.Journal of Clinical Investigation, 1966